Indomethacin Dosing for Acute Gout

Recommended Dosing Regimen

The American College of Physicians recommends an initial dose of indomethacin at 50 mg three times daily for 2-3 days, followed by 25 mg three times daily for an additional 3-5 days until symptoms resolve, with a total treatment duration of 5-7 days or until pain and inflammation resolve in patients with acute gout 1

Indomethacin provides effective pain relief in acute gout attacks, with significant improvement typically observed within 24-36 hours in patients with acute gout, according to the American College of Rheumatology 1, 2
Treatment should be initiated as soon as possible after symptom onset, ideally within 24 hours, and ongoing urate-lowering therapy should not be interrupted during an acute gout attack, as recommended by the American College of Rheumatology 3

Gastrointestinal adverse events are common with indomethacin, reported in 55-63% of patients, significantly higher than with corticosteroid alternatives, according to the American College of Gastroenterology 1, 2
Contraindications to indomethacin include severe renal impairment, history of GI bleeding or ulceration, and heart failure, as stated by the American Heart Association 4

Oral corticosteroids, such as prednisolone 30-35 mg daily for 5 days, provide similar efficacy to indomethacin with fewer adverse events in patients with acute gout, according to the American College of Rheumatology 1, 2
Low-dose colchicine, 1.2 mg followed by 0.6 mg one hour later, is effective if started within 36 hours of symptom onset in patients with acute gout, as recommended by the American College of Rheumatology 3

Confirm diagnosis of acute gout and assess for contraindications to NSAIDs, such as renal impairment, GI risk, and heart failure, before initiating treatment with indomethacin, as recommended by the American College of Rheumatology 3, 4

Continuing high-dose indomethacin beyond 2-3 days increases risk of adverse effects without additional benefit in patients with acute gout, according to the American College of Physicians 1
Failure to provide prophylaxis when initiating urate-lowering therapy can lead to symptom recurrence, as stated by the American College of Rheumatology 3, 5

The American College of Physicians recommends avoiding indomethacin in patients with cirrhosis 6
The American College of Physicians also recommends considering corticosteroids as first-line therapy in patients without contraindications because they are generally safer with fewer adverse effects than NSAIDs 6, 7

The American College of Physicians recommends corticosteroids, NSAIDs, or colchicine as equally effective first-line options for acute gout 6
Low-dose colchicine is effective if started within 36 hours of symptom onset, with a dosage of 1.2 mg followed by 0.6 mg one hour later (maximum 1.8 mg over one hour) 6
Other NSAIDs (naproxen, ibuprofen) are equally effective as indomethacin with potentially fewer side effects, according to moderate-quality evidence 6, 7

Urate-lowering therapy should not be initiated during an acute attack, according to the American College of Physicians 6
For patients with recurrent gout (≥2 episodes per year), urate-lowering therapy should be discussed after the acute attack resolves 6